Rich Book Covid-19 Jabs Abroad to Skip U.K. Wait, Telegraph Says
(Bloomberg) -- Super-rich and high-profile Britons are increasingly opting to travel abroad to get a private vaccine against the coronavirus, the Telegraph reported on Saturday.
Bookings for jabs in the United Arab Emirates, combined with beach breaks between the two doses of the vaccine, are becoming popular with private concierge service Knightsbridge Circle, which charges 25,000 pounds ($33,900) a year and lists royals, celebrities and business executives among its clients.
“Dubai and Abu Dhabi are already offering private appointments for the Pfizer vaccine,” Stuart McNeill, who runs the service, told the newspaper. “About 20% of our clients have opted to fly out and get it.”
The option allows the super-wealthy to get earlier inoculation as Britain currently only offers vaccines to people aged 80 and over, people who live or work in care homes and health and social-care workers at high risk.
Can Johnson Defy Critics and Vaccinate 15 Million Britons in Time?
While travel is banned as the U.K. is in its third strict lockdown in an attempt to curb a rapid increase in infections and deaths, business trips are allowed. The wealthy can use that as a pretext, the newspaper said.
Russia, which is rolling out its Sputnik V vaccine, is another destination for travel to get a jab. U.S. film director Oliver Stone, who won an Academy Award as a writer for Midnight Express, received a coronavirus shot in Russia in early December.
The AstraZeneca Plc and University of Oxford vaccine could be available for purchase in India as soon as March, according to the report.
©2021 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.